z-logo
open-access-imgOpen Access
Bufalin attenuates triple‑negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
Author(s) -
Fei Chen,
Li Zhu,
Junyan Hu,
Shujun Jiang,
Hui Liu,
Jie Zheng,
Jiandong Wang,
Feng Wang,
Zhe Li
Publication year - 2020
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2020.12028
Subject(s) - sox2 , triple negative breast cancer , cancer research , bufalin , cell cycle , oncogene , cancer stem cell , cancer , cell growth , stem cell , homeobox protein nanog , breast cancer , biology , medicine , apoptosis , transcription factor , induced pluripotent stem cell , microbiology and biotechnology , embryonic stem cell , biochemistry , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom